Jim Cramer's Latest Post

My Top S&P 500 Performers

More Trading Strategies

By

Roger Arnold

 | Aug 26, 2014 | 5:00 PM EDT |
The probable trajectories over the next few months.
By

James "Rev Shark" DePorre

 | Aug 26, 2014 | 4:19 PM EDT |
Fear of being left out is still driving the buyers.
By

Martin Tillier

 | Aug 26, 2014 | 4:00 PM EDT |
Increased mergers-and-acquisitions activity is a not a worry.
By

Jim Cramer

 | Aug 26, 2014 | 3:15 PM EDT |
These 15 names are inexpensive and easy to embrace.
By

Sham Gad

 | Aug 26, 2014 | 3:00 PM EDT |
The South Korean steel giant is poised to rise again.
By

Eric Jackson

 | Aug 26, 2014 | 2:16 PM EDT |
What you have to ask is how much a user is worth.
By

Tim Melvin

 | Aug 26, 2014 | 2:00 PM EDT |
This metric should be in every value investor's toolbox.
By

Mike Norman

 | Aug 26, 2014 | 1:00 PM EDT |
The ECB is secretly buying dollars to keep the euro down.
By

Kate Stalter

 | Aug 26, 2014 | 12:00 PM EDT |
Institutional-style diversification aims to mitigate risk.
By

Jim Cramer

 | Aug 26, 2014 | 11:48 AM EDT |
Buy stock in Starbucks and Chipotle instead.
By

Howard Simons

 | Aug 26, 2014 | 11:30 AM EDT |
Let's take a look at investment-grade and high-yield corporate bonds.
By

Chris Laudani

 | Aug 26, 2014 | 11:00 AM EDT |
Salesforce.com is about to become more attractive.
By

Herb Greenberg

 | Aug 26, 2014 | 10:12 AM EDT |
That is not a good business model.
By

Paul Price

 | Aug 26, 2014 | 10:00 AM EDT |
If you hold it at a large profit, consider cashing in on some.
By

Brian Sozzi

 | Aug 26, 2014 | 9:27 AM EDT |
International performance continues to be dreadful.

Upgrades & Downgrades

Aug 26, 2014 | 7:24 AM EDT
Shares of OSIS now seen reaching $82, acccording to Benchmark. Estimates also increased, given the company's new guidance. Buy rating. …
Bullish
Aug 26, 2014 | 7:23 AM EDT
JAH was initiated with a Buy rating, Deutsche Bank said. $70 price target. Stock is cheap, relative to the company's growth potential.&…
Bullish
Aug 26, 2014 | 7:21 AM EDT
AMG was placed on the Focus List, Credit Suisse said. $260 price target. Recently hosted positive meetings with management. Outperform …
Bullish
Aug 26, 2014 | 7:19 AM EDT
GS was initiated with a Buy rating, MKM Partners said. $213 price target. Believe the company can post ROE expansion.
Update
Aug 26, 2014 | 6:43 AM EDT
10am: Richmond Fed Manufacturing Index, Aug., est. 6 (prior     7)
Paul - The BRLI looks like just a bad 100 share trade out of over 10,000 shares traded. I ...
Sometimes we just want to look at charts... this will be the first in a series of just tha...
Laboratory testing company Bio-Reference Labs (BRLI) was up 5.66%, at $33.58, as of 5:37 P...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.